APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Biopsy Instruments and Kits

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cancer Biopsy Instruments and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17442326024 July 2026199 pages

Choose your research edition.

Industry ResearchCancer Biopsy Instruments and Kits Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Biopsy Instruments and Kits Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cancer Biopsy Instruments and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Biopsy Instruments and Kits Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Biopsy Instruments and Kits Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cancer Biopsy Instruments and Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Biopsy Instruments and Kits include QIAGEN NV, ANGLE plc, Becton, Dickinson and Company, BIOCEPT, INC., Danaher Corporation, Hologic, Inc., Illumina, Inc., Lucence Diagnostics Pte. Ltd. and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cancer Biopsy Instruments and Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Biopsy Instruments and Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Biopsy Instruments and Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cancer Biopsy Instruments and Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Biopsy Instruments and Kits Segment by Company

QIAGEN NV

ANGLE plc

Becton, Dickinson and Company

BIOCEPT, INC.

Danaher Corporation

Hologic, Inc.

Illumina, Inc.

Lucence Diagnostics Pte. Ltd.

Myriad Genetics

Thermo Fisher Scientific, Inc.

Cancer Biopsy Instruments and Kits Segment by Type

Cancer Biopsy Instruments

Cancer Biopsy Kits

Cancer Biopsy Instruments and Kits Segment by Application

Breast Cancer

Colorectal Cancer

Cervical Cancer

Lung Cancer

Others

Cancer Biopsy Instruments and Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Biopsy Instruments and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Biopsy Instruments and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Biopsy Instruments and Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cancer Biopsy Instruments and Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cancer Biopsy Instruments and Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cancer Biopsy Instruments and Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cancer Biopsy Instruments and Kits Industry Trends Table 2. Cancer Biopsy Instruments and Kits Industry Drivers Table 3. Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges Table 4. Cancer Biopsy Instruments and Kits Industry Restraints Table 5. Global Cancer Biopsy Instruments and Kits Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cancer Biopsy Instruments and Kits Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Cancer Biopsy Instruments and Kits Sales Market Share by Manufacturers Table 9. Global Cancer Biopsy Instruments and Kits Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Cancer Biopsy Instruments and Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cancer Biopsy Instruments and Kits Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cancer Biopsy Instruments and Kits Manufacturers, Product Type & Application Table 13. Global Cancer Biopsy Instruments and Kits Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cancer Biopsy Instruments and Kits by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cancer Biopsy Instruments Table 17. Major Manufacturers of Cancer Biopsy Kits Table 18. Global Cancer Biopsy Instruments and Kits Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 20. Global Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 21. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2026) Table 22. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2027-2032) Table 23. Global Cancer Biopsy Instruments and Kits Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (k units) Table 25. Global Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (k units) Table 26. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2026) Table 27. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Breast Cancer Table 29. Major Manufacturers of Colorectal Cancer Table 30. Major Manufacturers of Cervical Cancer Table 31. Major Manufacturers of Lung Cancer Table 32. Major Manufacturers of Others Table 33. Global Cancer Biopsy Instruments and Kits Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 35. Global Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 36. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2026) Table 37. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2027-2032) Table 38. Global Cancer Biopsy Instruments and Kits Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (k units) Table 40. Global Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (k units) Table 41. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2026) Table 42. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2027-2032) Table 43. Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026) & (k units) Table 45. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2021-2026) Table 46. Global Cancer Biopsy Instruments and Kits Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Cancer Biopsy Instruments and Kits Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 50. North America Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 51. Europe Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 53. Europe Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 60. Global Cancer Biopsy Instruments and Kits Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Cancer Biopsy Instruments and Kits Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Cancer Biopsy Instruments and Kits Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2021-2026) Table 64. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2027-2032) Table 65. QIAGEN NV Company Information Table 66. QIAGEN NV Business Overview Table 67. QIAGEN NV Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio Table 69. QIAGEN NV Recent Development Table 70. ANGLE plc Company Information Table 71. ANGLE plc Business Overview Table 72. ANGLE plc Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio Table 74. ANGLE plc Recent Development Table 75. Becton, Dickinson and Company Company Information Table 76. Becton, Dickinson and Company Business Overview Table 77. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio Table 79. Becton, Dickinson and Company Recent Development Table 80. BIOCEPT, INC. Company Information Table 81. BIOCEPT, INC. Business Overview Table 82. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio Table 84. BIOCEPT, INC. Recent Development Table 85. Danaher Corporation Company Information Table 86. Danaher Corporation Business Overview Table 87. Danaher Corporation Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio Table 89. Danaher Corporation Recent Development Table 90. Hologic, Inc. Company Information Table 91. Hologic, Inc. Business Overview Table 92. Hologic, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 94. Hologic, Inc. Recent Development Table 95. Illumina, Inc. Company Information Table 96. Illumina, Inc. Business Overview Table 97. Illumina, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 99. Illumina, Inc. Recent Development Table 100. Lucence Diagnostics Pte. Ltd. Company Information Table 101. Lucence Diagnostics Pte. Ltd. Business Overview Table 102. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio Table 104. Lucence Diagnostics Pte. Ltd. Recent Development Table 105. Myriad Genetics Company Information Table 106. Myriad Genetics Business Overview Table 107. Myriad Genetics Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio Table 109. Myriad Genetics Recent Development Table 110. Thermo Fisher Scientific, Inc. Company Information Table 111. Thermo Fisher Scientific, Inc. Business Overview Table 112. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 114. Thermo Fisher Scientific, Inc. Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Cancer Biopsy Instruments and Kits Distributors List Table 118. Cancer Biopsy Instruments and Kits Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Cancer Biopsy Instruments and Kits Product Image Figure 2. Global Cancer Biopsy Instruments and Kits Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Biopsy Instruments and Kits Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Biopsy Instruments and Kits Sales (2021-2032) & (k units) Figure 5. Global Cancer Biopsy Instruments and Kits Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cancer Biopsy Instruments and Kits Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cancer Biopsy Instruments Image Figure 9. Cancer Biopsy Kits Image Figure 10. Global Cancer Biopsy Instruments and Kits Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Cancer Biopsy Instruments and Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2032) Figure 13. Global Cancer Biopsy Instruments and Kits Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Cancer Biopsy Instruments and Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2032) Figure 16. Breast Cancer Image Figure 17. Colorectal Cancer Image Figure 18. Cervical Cancer Image Figure 19. Lung Cancer Image Figure 20. Others Image Figure 21. Global Cancer Biopsy Instruments and Kits Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Cancer Biopsy Instruments and Kits Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2032) Figure 24. Global Cancer Biopsy Instruments and Kits Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Cancer Biopsy Instruments and Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2032) Figure 27. North America Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2032) Figure 29. U.S. Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2032) Figure 34. Germany Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2032) Figure 41. China Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2032) Figure 49. Brazil Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Cancer Biopsy Instruments and Kits Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Cancer Biopsy Instruments and Kits Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Figure 60. North America Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Figure 62. Europe Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cancer Biopsy Instruments and Kits Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Cancer Biopsy Instruments and Kits Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Cancer Biopsy Instruments
  • Cancer Biopsy Kits
Applications
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others
Companies covered
  • QIAGEN NV
  • ANGLE plc
  • Becton, Dickinson and Company
  • BIOCEPT, INC.
  • Danaher Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Myriad Genetics
  • Thermo Fisher Scientific, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cancer Biopsy Instruments and Kits Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cancer Biopsy Instruments and Kits Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cancer Biopsy Instruments and Kits Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cancer Biopsy Instruments and Kits Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cancer Biopsy Instruments and Kits Market Dynamics
  1. 2.1 Cancer Biopsy Instruments and Kits Industry Trends
  2. 2.2 Cancer Biopsy Instruments and Kits Industry Drivers
  3. 2.3 Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges
  4. 2.4 Cancer Biopsy Instruments and Kits Industry Restraints
3 Cancer Biopsy Instruments and Kits Market by Manufacturers
  1. 3.1 Global Cancer Biopsy Instruments and Kits Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cancer Biopsy Instruments and Kits Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cancer Biopsy Instruments and Kits Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cancer Biopsy Instruments and Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Biopsy Instruments and Kits Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cancer Biopsy Instruments and Kits Manufacturers, Product Type & Application
  7. 3.7 Global Cancer Biopsy Instruments and Kits Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Biopsy Instruments and Kits Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Biopsy Instruments and Kits Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Biopsy Instruments and Kits Tier 1, Tier 2, and Tier 3
4 Cancer Biopsy Instruments and Kits Market by Type
  1. 4.1 Cancer Biopsy Instruments and Kits Type Introduction
  2. 4.1.1 Cancer Biopsy Instruments
  3. 4.1.2 Cancer Biopsy Kits
  4. 4.2 Global Cancer Biopsy Instruments and Kits Sales by Type
  5. 4.2.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
  7. 4.2.3 Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cancer Biopsy Instruments and Kits Revenue by Type
  9. 4.3.1 Global Cancer Biopsy Instruments and Kits Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
  11. 4.3.3 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2032)
5 Cancer Biopsy Instruments and Kits Market by Application
  1. 5.1 Cancer Biopsy Instruments and Kits Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Colorectal Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Cancer Biopsy Instruments and Kits Sales by Application
  8. 5.2.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
  10. 5.2.3 Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2032)
  11. 5.3 Global Cancer Biopsy Instruments and Kits Revenue by Application
  12. 5.3.1 Global Cancer Biopsy Instruments and Kits Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
  14. 5.3.3 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2032)
6 Global Cancer Biopsy Instruments and Kits Sales by Region
  1. 6.1 Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026)
  4. 6.2.2 Global Cancer Biopsy Instruments and Kits Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cancer Biopsy Instruments and Kits Revenue by Region
  1. 7.1 Global Cancer Biopsy Instruments and Kits Revenue by Region
  2. 7.1.1 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cancer Biopsy Instruments and Kits Revenue by Region (2021-2026)
  4. 7.1.3 Global Cancer Biopsy Instruments and Kits Revenue by Region (2027-2032)
  5. 7.1.4 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cancer Biopsy Instruments and Kits Revenue (2021-2032)
  8. 7.2.2 North America Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cancer Biopsy Instruments and Kits Revenue (2021-2032)
  11. 7.3.2 Europe Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cancer Biopsy Instruments and Kits Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cancer Biopsy Instruments and Kits Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cancer Biopsy Instruments and Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 QIAGEN NV
  2. 8.1.1 QIAGEN NV Company Information
  3. 8.1.2 QIAGEN NV Business Overview
  4. 8.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
  6. 8.1.5 QIAGEN NV Recent Developments
  7. 8.2 ANGLE plc
  8. 8.2.1 ANGLE plc Company Information
  9. 8.2.2 ANGLE plc Business Overview
  10. 8.2.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
  12. 8.2.5 ANGLE plc Recent Developments
  13. 8.3 Becton, Dickinson and Company
  14. 8.3.1 Becton, Dickinson and Company Company Information
  15. 8.3.2 Becton, Dickinson and Company Business Overview
  16. 8.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
  18. 8.3.5 Becton, Dickinson and Company Recent Developments
  19. 8.4 BIOCEPT, INC.
  20. 8.4.1 BIOCEPT, INC. Company Information
  21. 8.4.2 BIOCEPT, INC. Business Overview
  22. 8.4.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
  24. 8.4.5 BIOCEPT, INC. Recent Developments
  25. 8.5 Danaher Corporation
  26. 8.5.1 Danaher Corporation Company Information
  27. 8.5.2 Danaher Corporation Business Overview
  28. 8.5.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
  30. 8.5.5 Danaher Corporation Recent Developments
  31. 8.6 Hologic, Inc.
  32. 8.6.1 Hologic, Inc. Company Information
  33. 8.6.2 Hologic, Inc. Business Overview
  34. 8.6.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  36. 8.6.5 Hologic, Inc. Recent Developments
  37. 8.7 Illumina, Inc.
  38. 8.7.1 Illumina, Inc. Company Information
  39. 8.7.2 Illumina, Inc. Business Overview
  40. 8.7.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  42. 8.7.5 Illumina, Inc. Recent Developments
  43. 8.8 Lucence Diagnostics Pte. Ltd.
  44. 8.8.1 Lucence Diagnostics Pte. Ltd. Company Information
  45. 8.8.2 Lucence Diagnostics Pte. Ltd. Business Overview
  46. 8.8.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
  48. 8.8.5 Lucence Diagnostics Pte. Ltd. Recent Developments
  49. 8.9 Myriad Genetics
  50. 8.9.1 Myriad Genetics Company Information
  51. 8.9.2 Myriad Genetics Business Overview
  52. 8.9.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
  54. 8.9.5 Myriad Genetics Recent Developments
  55. 8.10 Thermo Fisher Scientific, Inc.
  56. 8.10.1 Thermo Fisher Scientific, Inc. Company Information
  57. 8.10.2 Thermo Fisher Scientific, Inc. Business Overview
  58. 8.10.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cancer Biopsy Instruments and Kits Value Chain Analysis
  2. 9.1.1 Cancer Biopsy Instruments and Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cancer Biopsy Instruments and Kits Production Mode & Process
  6. 9.2 Cancer Biopsy Instruments and Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cancer Biopsy Instruments and Kits Distributors
  9. 9.2.3 Cancer Biopsy Instruments and Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst